Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...

Although the COVID pandemic led to a better understanding of the coronaviruses, viruses, and vaccines, a backlash emerged to ...

What did we learn during the pandemic and how do we prepare for the next one? That was the theme when representatives from academia, healthcare, authorities, politics and media met during two ...

In a recent essay, Jay Bhattacharya, director of the National Institutes of Health, laid out a strikingly different vision for how the United States should prepare for the next pandemic: do almost ...

In the event of a sudden pandemic, what should we do? This month, Jay Bhattacharya, the director of the National Institutes of Health, offered a remarkably blunt answer: nothing. It’s been nearly six ...

Listen to more stories on the Noa app. Last week, the two top officials at the National Institutes of Health—the world’s largest public funder of biomedical research—debuted a new plan to help ...

“The world needs a new pandemic playbook,” headlined City Journal on Nov. 13, because “the old one failed to cope with Covid and may even have caused it.” The author is Dr. Jay Bhattacharya, director ...

Story On a Friday morning in October, about 100 high school and college students gathered in a Utah ballroom to play a game. Some students were assigned specific roles and given costumes to wear.

In 2025, more than 3,800 research grants from the National Institutes of Health and the National Science Foundation were terminated or frozen as part of the Trump administration’s effort to realign ...